Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
Published

The Danish severe asthma register: an electronic platform for severe asthma management and research

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Witnessed sleep apneas together with elevated plasma glucose are predictors of COPD exacerbations

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Clinical characteristics of the BREATHE cohort - a real-life study on patients with asthma and COPD

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Elevated blood eosinophils in acute COPD exacerbations: better short- and long-term prognosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Household dampness and microbial exposure related to allergy and respiratory health in Danish adults

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Direct effects of mast cell proteases, tryptase and chymase, on bronchial epithelial integrity proteins and anti-viral responses

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The Prevalence of Subtypes of Type 2 Inflammation in an Unselected Population of Patients with Severe Asthma

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Antibiotics during childhood and development of appendicitis-a nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The evaluation and management of severe asthma patients require collection of comprehensive information, which is often a challenge in a busy outpatient clinic. The Danish Severe Asthma Register (DSAR) was designed as an electronic patient record form that captures operational clinical data and provides a clinical overview of the severe asthma patient. DSAR is a nationwide register; all patients in Denmark who are treated with biologics for severe asthma are included, and data are as a minimum entered at start of biological treatment, after four and 12 months of treatment, and hereafter annually. Currently, there are data from 621 treatment courses with biologics included in DSAR, with 71% of patients treated with anti-IL-5 drugs and 29% with an anti-IgE drug. Patients enter Patient Reported Outcome Measures electronically on tablets when they arrive in the outpatient clinic and their answers are immediately available to the clinician during the consultation. Nurses and doctors enter clinical data into DSAR during the consultation. DSAR offers immediate access to well-presented longitudinal overview and automatically creates a journal output that can be copy-pasted into the hospital's existing health record form. DSAR is also currently expanding with an app, to be used for monitoring of home-treatment. In addition to serving as an electronic patient record form, DSAR will also provide opportunities to monitor the real-life efficacy of biological treatment for severe asthma in Denmark, and it will be a valuable research platform that will aid in answering important research questions on severe asthma in the future.

Original languageEnglish
Article number1842117
JournalEuropean Clinical Respiratory Journal
Volume8
Issue number1
Pages (from-to)1-13
Number of pages13
ISSN2001-8525
DOIs
Publication statusPublished - 2021

    Research areas

  • Severe asthma, biological treatment, clinical decision-making tool, electronic patient record, real-life efficacy, severe asthma research

ID: 61308276